ClinicalTrials.gov
public full text
Public Domain
Autologous CD4 T-Cells in HIV (C34-CXCR4)
A single cohort, open-label pilot study of the safety and tolerability of a single infusion of autologous CD4+ T-cells genetically modified with an HR2, C34-peptide conjugated to the CXCR4 N-terminus using a lentiviral vector in HIV-infected subjects. This is a first in human study of C34-CXCR4 T cells
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease#1311404
- Efficacy Study of T Cell Vaccination in HIV Infection#994908
- Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection#609404
- Maraviroc in Immunological Non-Responder (INR) HIV-1-infected Subjects#1100957
- Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma#1230869
Record · ID 1280110
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive